{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/30/3285496/0/en/Cue-Biopharma-Expands-Pipeline-with-Exclusive-License-from-Ascendant-Health-Sciences-Ltd-for-Clinical-Stage-Dual-Mechanism-Anti-IgE-Antibody.html", "message": "News view counter 695405 successfully enlarged"}